All Sauce from Weekly Sauce:

A proposed U.S. federal ban on menthol cigarettes doesn’t go far enough and needs to include other menthol products, from pipe tobacco to cigarette tubes, researchers say. New evidence shows both the appeal and the addiction potential of these substitutes in adults who smoke menthol cigarettes, said scientists from Rutgers University Center for Tobacco Studies…  read on >  read on >

That special link you may have with a purring, four-legged friend has been going on between the species for millennia, new research shows. The human-cat relationship was probably forged over a shared interest in rats more than 10,000 years ago, investigators say. As farming became a way of life, cats served as ancient pest control,…  read on >  read on >

Some Americans appear to be moving from areas with frequent hurricanes and heat waves to places threatened by wildfire and rising heat. They’re trading in the risk of one set of natural disasters for another because the wildfires are only beginning to become a national issue, according to researchers. “These findings are concerning, because people…  read on >  read on >

The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available — at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. Instead, it will be billed for like many other medications. While the Biden administration has paid…  read on >  read on >

Many Americans believe that suicide rates spike every time the holiday season comes around. There’s just one catch: It’s not true. Yet, a new analysis reveals that 56% of stories published last year in U.S. newspapers that touched on a potential connection between the holidays and suicide perpetuated the falsehood. Only 44% debunked the notion.…  read on >  read on >

One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests. Among 106 patients with “wet” age-related macular degeneration, 50% of those treated with aflibercept (Eylea) could be weaned off the drug after one year, compared with only 17% of those treated…  read on >  read on >